【ANNOUNCEMENT SPEECH】Probiotic Regulation and Product Innovation
Save the date! Co-organized by Taiwan CNFI and Thailand F.T.I., the “2022 Taiwan – Thailand Industrial Collaboration Summit” will be held live between 2 venues in Taiwan and Thailand via video conference from September 21st to 22nd.
Dr. Pan Tzu-Ming, Vice President of SunWay Biotech was invited to share his lifelong knowledge of probiotics. It will keep you up-to-date on probiotic market trends, regulations, and product development ideas. Welcome to join us!
🎤Topic: Probiotic Regulation and Product Innovation
🗣Speaker: Pan Tzu-Ming, Honorary Director, Taiwan Association for Lactic Acid Bacteria/Vice President of SunWay Biotech
🗓️Time: Sep 21, 2022; 15:15-15:55 (TW)/14:15-14:55(Thai)
📍Location: Taiwan & Thailand (via video conference)
Taiwan live conference: Courtyard By Marriott Taipei Downtown
Thailand live conference: The Sukosol Hotel
2022 TTICoS schedule👉
https://tticos.com/#home
Related posts
Meet Us at SupplySide West 2015 in Las Vegas during October 7-8 and Fi Europe & Ni 2015 in Paris during December 1-3
This year, we are going to exhibit at SupplySide West 2015 in Las Vegas during October 7-8 and Fi Europe & Ni 2015 in Paris during December 1-3. We will exhibit our multi-functional dietary ingredients － ANKASCIN 568-R and Vigiis 101-Probiotic. Remarkable advances have been made in the development of ANKASCIN 568-R. During the exhibitions, we will share the information on our New Dietary Ingredient approval by the US FDA as well as two clinical trials on blood lipid and blood sugar regulation. You are welcome to meet and visit us at stand # 1263 at SupplySide West 2015 and stand # 7B14 at Fi Europe & Ni 2015. Visit us for the innovative multi-functional dietary ingredients! We look forward to meeting you at SupplySide West 2015 and Fi Europe & Ni 2015.
Hi Europe & Ni, 2-4 December 2014
Time：2014/12/02~2015/12/04 Place：Amsterdam, The Netherlands Booth No：K84
White Paper－The Vigiis 101-LAB, provides bodywide microbiome benefits with just one ingredient
This white paper will expose the remaining untapped market potential for probiotics, as well as the role Vigiis® 101-LAB can play in meeting consumer needs for complete probiotic support across the microbiome. • USD $78.3 billion will be reached by global probiotics market in 2026 • Constipation affecting 16% of US adults and 33% of US seniors • COVID-19 has rocketed sales of immune health supplements up 25 percent in 2020, with expected impact in probiotics.